Home

daru Elvárás Kiemelkedő counter screen assay Igazítsa Il árnyék

Counter-screen of three inhibitors. Concentration–response plots are... |  Download Scientific Diagram
Counter-screen of three inhibitors. Concentration–response plots are... | Download Scientific Diagram

Identification of HMGA2 inhibitors by AlphaScreen-based  ultra-high-throughput screening assays | Scientific Reports
Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays | Scientific Reports

Applications of chemogenomic library screening in drug discovery | Nature  Reviews Drug Discovery
Applications of chemogenomic library screening in drug discovery | Nature Reviews Drug Discovery

Creating and screening natural product libraries - Natural Product Reports  (RSC Publishing) DOI:10.1039/C9NP00068B
Creating and screening natural product libraries - Natural Product Reports (RSC Publishing) DOI:10.1039/C9NP00068B

A High Throughput Screen for RGS Proteins Using Steady State Monitoring of  Free Phosphate Formation | PLOS ONE
A High Throughput Screen for RGS Proteins Using Steady State Monitoring of Free Phosphate Formation | PLOS ONE

Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative  High-Throughput Screening | ACS Pharmacology & Translational Science
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening | ACS Pharmacology & Translational Science

SCREENING QUALITY CONTROLS – A KEY ISSUE FOR ROBUST ASSAY EXECUTION -  Selvita
SCREENING QUALITY CONTROLS – A KEY ISSUE FOR ROBUST ASSAY EXECUTION - Selvita

Quantitative high-throughput screening assays for the discovery and  development of SIRPα-CD47 interaction inhibitors | PLOS ONE
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors | PLOS ONE

ASSAY DEVELOPMENT IN DRUG DISCOVERY
ASSAY DEVELOPMENT IN DRUG DISCOVERY

Development of an AlphaLISA protein-protein interaction assay to screen for  re-purposed drugs as targeted disruptors | BMG LABTECH
Development of an AlphaLISA protein-protein interaction assay to screen for re-purposed drugs as targeted disruptors | BMG LABTECH

ASSAY DEVELOPMENT IN DRUG DISCOVERY
ASSAY DEVELOPMENT IN DRUG DISCOVERY

Orthogonal assays for the identification of inhibitors of the  single-stranded nucleic acid binding protein YB-1 - ScienceDirect
Orthogonal assays for the identification of inhibitors of the single-stranded nucleic acid binding protein YB-1 - ScienceDirect

TDP2 counter-screening assay. A, schematic representation of the... |  Download Scientific Diagram
TDP2 counter-screening assay. A, schematic representation of the... | Download Scientific Diagram

Quantitative high-throughput screening assays for the discovery and  development of SIRPα-CD47 interaction inhibitors | PLOS ONE
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors | PLOS ONE

Statistical practice in high-throughput screening data analysis | Nature  Biotechnology
Statistical practice in high-throughput screening data analysis | Nature Biotechnology

A Phenotypic Approach for the Identification of New Molecules for Targeted  Protein Degradation Applications - ScienceDirect
A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications - ScienceDirect

Establishing assays and small molecule screening facilities for Drug  discovery programs - European Pharmaceutical Review
Establishing assays and small molecule screening facilities for Drug discovery programs - European Pharmaceutical Review

Synergy Screening Identifies a Compound That Selectively Enhances the  Antibacterial Activity of Nitric Oxide - Frontiers
Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric Oxide - Frontiers

Figure 6, [TruHit counter-screen flags compounds that...]. - Assay Guidance  Manual - NCBI Bookshelf
Figure 6, [TruHit counter-screen flags compounds that...]. - Assay Guidance Manual - NCBI Bookshelf

A Checklist for Validating Phenotypic Hits - Blog - PostEra
A Checklist for Validating Phenotypic Hits - Blog - PostEra

Screen and counter screen protocol followed in virtual screening for... |  Download Scientific Diagram
Screen and counter screen protocol followed in virtual screening for... | Download Scientific Diagram

Characterization of inhibitors with the counter screen assay and... |  Download Scientific Diagram
Characterization of inhibitors with the counter screen assay and... | Download Scientific Diagram

Identification of activators of human fumarate hydratase by quantitative  high-throughput screening | bioRxiv
Identification of activators of human fumarate hydratase by quantitative high-throughput screening | bioRxiv

Primary Assay and Counterscreen Results for Three Hits from the LOPAC... |  Download Table
Primary Assay and Counterscreen Results for Three Hits from the LOPAC... | Download Table

Figure 10, [Schematic of an antibody-based counter-screen...]. - Assay  Guidance Manual - NCBI Bookshelf
Figure 10, [Schematic of an antibody-based counter-screen...]. - Assay Guidance Manual - NCBI Bookshelf

Dealing with PAINs in a drug discovery CRO - Sygnature Discovery
Dealing with PAINs in a drug discovery CRO - Sygnature Discovery

HIGH THROUGHPUT SCREENING DONE RIGHT | Multispan, Inc
HIGH THROUGHPUT SCREENING DONE RIGHT | Multispan, Inc

Figure 2, CID 1245700 was tested across a range of concentrations up to 10  μM in the primary assay and secondary counter screen, up to 25 μM in  mammalian cytotoxicity assays, and
Figure 2, CID 1245700 was tested across a range of concentrations up to 10 μM in the primary assay and secondary counter screen, up to 25 μM in mammalian cytotoxicity assays, and